Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive review on Covid-19 Omicron (B.1.1.529) variant. | Saudi J Biol Sci | 2022 | 35855306 | PubTator, text mining | PubMed |
| Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. | Signal Transduct Target Ther | 2022 | 35853878 | PubTator, text mining | PubMed |
| Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. | Front Microbiol | 2022 | 35847101 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection. | Front Pharmacol | 2022 | 35847031 | PubTator, text mining | PubMed |
| Paxlovid: Mechanism of Action, Synthesis, and In Silico Study. | Biomed Res Int | 2022 | 35845944 | PubTator, text mining | PubMed |
| Chemistry of Protein-Phenolic Interactions Toward the Microbiota and Microbial Infections. | Front Nutr | 2022 | 35845785 | PubTator, text mining | PubMed |
| Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease. | Sci Rep | 2022 | 35842458 | PubTator, text mining | PubMed |
| The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses. | Cell Mol Life Sci | 2022 | 35841484 | PubTator, text mining | PubMed |
| Reinventing positive-strand RNA virus reverse genetics. | Adv Virus Res | 2022 | 35840179 | PubTator, text mining | PubMed |
| Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina. | BMC Genomics | 2022 | 35836127 | PubTator, text mining | PubMed |
| Allosteric inhibitors of the main protease of SARS-CoV-2. | Antiviral Res | 2022 | 35835291 | PubTator, text mining | PubMed |
Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2. | PLoS One | 2022 | 35830431 | PubTator, text mining | PubMed |
| The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs. | J Genet Eng Biotechnol | 2022 | 35829826 | PubTator, text mining | PubMed |
| Developmental programming: Impact of prenatal bisphenol-A exposure on liver and muscle transcriptome of female sheep. | Toxicol Appl Pharmacol | 2022 | 35817127 | PubTator, text mining | PubMed |
| GenomeBits insight into omicron and delta variants of coronavirus pathogen. | PLoS One | 2022 | 35816483 | PubTator, text mining | PubMed |
| Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches. | Struct Chem | 2022 | 35811783 | PubTator, text mining | PubMed |
| Fragment-based inhibitor design for SARS-CoV2 main protease. | Struct Chem | 2022 | 35811782 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2. | Comput Biol Med | 2022 | 35809412 | PubTator, text mining | PubMed |
| Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. | Molecules | 2022 | 35807550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=46